Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Perit Dial Int. 2010 Mar-Apr;30(2):178-86. doi: 10.3747/pdi.2008.00242. Epub 2010 Jan 15.
Endotoxemia is common in peritoneal dialysis (PD) patients; circulating lipopolysaccharide (LPS) level is related to the degree of systemic inflammation and atherosclerosis. We examine whether baseline plasma LPS level represents a prognostic marker in new PD patients.
We studied 158 new Chinese PD patients (80 males). Baseline plasma LPS level at initiation of PD was measured. Patients were stratified into quartiles according to plasma LPS level: quartile I, <0.45 EU/mL; II, 0.45 - <0.70 EU/mL; III, 0.70 - <0.95 EU/mL; and IV, ≥ 0.95 EU/mL. The patients were then prospectively followed for the development of cardiovascular events. All-cause mortality and duration of hospitalization were also recorded.
Average age was 55.6 +/- 14.7 years; average endotoxin concentration was 0.70 +/- 0.30 EU/mL; average follow-up was 55.5 +/- 36.9 months. At 60 months, event-free survival was 41.0%, 52.5%, 65.0%, and 61.5% for LPS level quartiles I, II, III, and IV, respectively (log rank test p = 0.066). By multivariate analysis with the Cox proportional hazard model to adjust for confounders, plasma LPS level had no independent effect. At 60 months, technique survival was 20.5%, 20.0%, 32.5%, and 51.3% for LPS level quartiles I, II, III, and IV, respectively (log rank test p = 0.0009). By Cox proportional hazard model, each higher quartile of LPS conferred 28.6% protection (95% confidence interval 15.6% - 40.3%, p = 0.0002) from developing technique failure. A higher plasma LPS level had a lower all-cause mortality (unadjusted hazard ratio 0.486, p = 0.046) and cardiovascular mortality (unadjusted hazard ratio 0.251, p = 0.025), but the result became insignificant after adjusting for potential confounders.
A higher baseline plasma LPS level is an independent predictor of better technique survival in new Chinese PD patients, with an insignificant trend of fewer cardiovascular events. The observation seems to conform to the phenomenon of reverse epidemiology for other traditional cardiovascular risk factors in dialysis patients but the exact reason for this paradoxical phenomenon requires further investigation.
内毒素血症在腹膜透析(PD)患者中很常见;循环脂多糖(LPS)水平与全身炎症和动脉粥样硬化的程度有关。我们研究了基线血浆 LPS 水平是否代表新 PD 患者的预后标志物。
我们研究了 158 名新的中国 PD 患者(80 名男性)。在开始 PD 时测量了基线血浆 LPS 水平。根据血浆 LPS 水平将患者分为四组:第 I 组,<0.45EU/mL;第 II 组,0.45-<0.70EU/mL;第 III 组,0.70-<0.95EU/mL;第 IV 组,≥0.95EU/mL。然后对患者进行前瞻性随访,以观察心血管事件的发生情况。还记录了全因死亡率和住院时间。
平均年龄为 55.6±14.7 岁;平均内毒素浓度为 0.70±0.30EU/mL;平均随访时间为 55.5±36.9 个月。在 60 个月时,LPS 水平分别为第 I、II、III 和 IV 四分位数的无事件生存率分别为 41.0%、52.5%、65.0%和 61.5%(对数秩检验,p=0.066)。通过多变量分析,使用 Cox 比例风险模型调整混杂因素,血浆 LPS 水平无独立影响。在 60 个月时,LPS 水平分别为第 I、II、III 和 IV 四分位数的技术生存率分别为 20.5%、20.0%、32.5%和 51.3%(对数秩检验,p=0.0009)。通过 Cox 比例风险模型,每个 LPS 四分位较高的患者发生技术失败的保护率分别为 28.6%(95%置信区间 15.6%-40.3%,p=0.0002)。较高的血浆 LPS 水平与全因死亡率较低相关(未调整的危险比 0.486,p=0.046)和心血管死亡率(未调整的危险比 0.251,p=0.025),但在调整了潜在混杂因素后,结果变得无统计学意义。
中国新 PD 患者基线血浆 LPS 水平较高是技术生存率较好的独立预测因子,心血管事件发生率呈下降趋势。这种观察结果似乎符合透析患者其他传统心血管危险因素的反向流行病学现象,但这种矛盾现象的确切原因需要进一步研究。